OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 94 filers reported holding OCULAR THERAPEUTIX INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,975 | -43.7% | 8,909 | -7.5% | 0.00% | – |
| Q2 2023 | $49,712 | +1.3% | 9,634 | +3.5% | 0.00% | – |
| Q1 2023 | $49,053 | +96.8% | 9,308 | +4.9% | 0.00% | – |
| Q4 2022 | $24,922 | -32.6% | 8,869 | 0.0% | 0.00% | – |
| Q3 2022 | $37,000 | 0.0% | 8,869 | -4.1% | 0.00% | – |
| Q2 2022 | $37,000 | -86.0% | 9,251 | -82.7% | 0.00% | – |
| Q1 2022 | $265,000 | -29.1% | 53,550 | 0.0% | 0.00% | – |
| Q4 2021 | $374,000 | +9.7% | 53,550 | +57.3% | 0.00% | – |
| Q3 2021 | $341,000 | +11.8% | 34,052 | +58.2% | 0.00% | – |
| Q2 2021 | $305,000 | -12.9% | 21,519 | +0.8% | 0.00% | – |
| Q1 2021 | $350,000 | -21.3% | 21,346 | -0.5% | 0.00% | – |
| Q4 2020 | $445,000 | +709.1% | 21,460 | +197.4% | 0.00% | – |
| Q3 2020 | $55,000 | -21.4% | 7,217 | -14.6% | 0.00% | – |
| Q2 2020 | $70,000 | +105.9% | 8,454 | +24.2% | 0.00% | – |
| Q1 2020 | $34,000 | +3.0% | 6,805 | -18.6% | 0.00% | – |
| Q4 2019 | $33,000 | +65.0% | 8,359 | +25.2% | 0.00% | – |
| Q3 2019 | $20,000 | -31.0% | 6,677 | 0.0% | 0.00% | – |
| Q2 2019 | $29,000 | +7.4% | 6,677 | 0.0% | 0.00% | – |
| Q1 2019 | $27,000 | +42.1% | 6,677 | +37.9% | 0.00% | – |
| Q4 2018 | $19,000 | -42.4% | 4,842 | 0.0% | 0.00% | – |
| Q3 2018 | $33,000 | 0.0% | 4,842 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | 0.0% | 4,842 | -4.7% | 0.00% | – |
| Q1 2018 | $33,000 | +22.2% | 5,083 | -14.9% | 0.00% | – |
| Q4 2017 | $27,000 | -28.9% | 5,975 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -30.9% | 5,975 | 0.0% | 0.00% | – |
| Q2 2017 | $55,000 | +96.4% | 5,975 | +96.2% | 0.00% | – |
| Q1 2017 | $28,000 | +12.0% | 3,045 | 0.0% | 0.00% | – |
| Q4 2016 | $25,000 | – | 3,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |